Double-blind Parallel Placebo-controlled Study to Evaluate the Effect of Molsidomine on the Endothelial Dysfunction in Patients With Stable Angina Pectoris Undergoing a Percutaneous Coronary Intervention.

Trial Profile

Double-blind Parallel Placebo-controlled Study to Evaluate the Effect of Molsidomine on the Endothelial Dysfunction in Patients With Stable Angina Pectoris Undergoing a Percutaneous Coronary Intervention.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2015

At a glance

  • Drugs Molsidomine (Primary)
  • Indications Angina pectoris
  • Focus Biomarker; Pharmacodynamics
  • Acronyms MEDCOR
  • Sponsors Therabel
  • Most Recent Events

    • 25 Sep 2014 Planned End Date changed from 1 Nov 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
    • 25 Sep 2014 Planned primary completion date changed from 1 Nov 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
    • 23 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top